Inventiva S.A. (EPA:IVA)
5.56
-0.12 (-2.11%)
Mar 11, 2026, 5:35 PM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €1.09 billion as of March 11, 2026. Its market cap has increased by 306.55% in one year.
Market Cap
1.09B
Enterprise Value
1.10B
Revenue
16.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.56
Market Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 1.09B, an increase of 706.47%. That is a compound annual growth rate of 25.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 1.06B | 40.94% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.32B |
| Nanobiotix | 1.62B |
| DBV Technologies | 1.12B |
| Valneva SE | 812.82M |
| MedinCell | 783.45M |
| Genfit | 442.93M |
| Cellectis | 228.55M |
| Transgene | 217.97M |